Fig. 5: Survival after CAR T failure (n = 62).

a OS and EFS for the 62 responding patients that subsequently failed CAR T. b OS and (c) EFS stratified according to type of CAR T failure. MRD measurable residual disease emergence, LBCA early loss of B-cell aplasia.